Clinical Trials Directory

Trials / Completed

CompletedNCT04278482

Effects of the Consumption of a Supplement Rich in Docosahexaenoic Acid (DHA) From Algae

"Diseño y Validación en Humanos de un Nuevo Complemento Alimenticio Rico en Ácido Docosahexaenoico (DHA) Procedente de Algas"

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
102 (actual)
Sponsor
National Research Council, Spain · Other Government
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Vegetarian diets are increasing worldwide. To prevent nutritional deficiencies, supplementation with nutrients that are only present in animal food can be needed. In relation to fatty acids, vegetarian diets involve low intake of omega-3 polyunsaturated fatty acids (n-3 PUFA) and low blood levels of the long-chain n-3 derivatives, whose main dietary sources are fish and shellfish, particularly the levels of docosahexaenoic acid (DHA), which has important health benefits, are low. In this regard, validation of supplements rich in the n-3 fatty acid DHA that are not obtained from fish is needed, thus the study will test the bioavailability and metabolic effects of a DHA supplement form algae. The study will be conducted on the effects of the DHA supplement versus placebo in vegetarian and non-vegetarian healthy adults.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDietary supplement, DHA or PlaceboConsumption of 2 capsules per day of the dietary supplement, DHA or Placebo

Timeline

Start date
2020-03-10
Primary completion
2021-07-05
Completion
2021-07-05
First posted
2020-02-20
Last updated
2023-01-17

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04278482. Inclusion in this directory is not an endorsement.